Dear Sirs, We refer to our letter dated September 28, 2018, informing you of our Board Meeting that was scheduled for today. Please note that the Board of Directors of Novartis India Limited met today and considered financial results of the Company for second quarter and half year ended September 30, 2018. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 3.20 p.m. We enclose a copy of the quarterly financial results approved at this meeting along with the Limited Review Report provided by Deloitte Haskins & Sells LLP, Statutory Auditors of the Company, for your information. We have made arrangements for publishing an extract of the above mentioned financial results as per the format prescribed under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015, in the selected newspapers
Source : BSE - www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.